Condensed Statements of Cash Flows (Unaudited) - USD ($)	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Cash Flows from Operating Activities:
Net income (loss)	$ 3,022,915	$ (1,183,957)
Adjustments to reconcile net income (loss) to net cash used in operating activities:
Interest earned on Trust Account	(3,620)	(1,294)
Increase in deferred legal costs	2,112,194
Change in fair value of warrant liabilities	(4,358,333)	348,666
Change in fair value of forward purchase agreement liabilities	(2,664,000)
Offering costs allocated to warrants		719,201
Changes in current assets and current liabilities:
Prepaid assets	73,638	(529,047)
Accounts payable and accrued expenses	1,372,375	592,749
Due to related party	30,043
Net cash used in operating activities	(414,788)	(53,682)
Cash Flows from Investing Activities:
Investment of cash into Trust Account		(345,000,000)
Net cash used in investing activities		(345,000,000)
Cash Flows from Financing Activities:
Proceeds from issuance of Founder Shares		25,000
Proceeds from Initial Public Offering, net of underwriters’ discount		338,100,000
Proceeds from issuance of Private Placement Warrants		8,900,000
Payments of offering costs		(521,631)
Net cash provided by financing activities		346,503,369
Net Change in Cash	(414,788)	1,449,687
Cash – Beginning	1,503,768
Cash – Ending	1,088,980	1,449,687
Supplemental Disclosure of Non-cash Financing Activities:
Initial value of warrant liabilities		18,190,000
Deferred underwriters’ discount payable charged to additional paid-in capital		12,075,000
Initial value of forward purchase agreement liabilities		$ 11,655,000